Archive | Resident Company News


Exact Sciences hires Mayo Clinic Dr. Paul Limburg as co-chief medical officer

Mayo Clinic gastroenterologist and professor of medicine Dr. Paul Limburg has joined Exact Sciences Corp. as co-chief medical officer. Limburg, a co-leader of the Cancer Prevention and Control program in the Mayo Clinic Cancer Center, will continue in his positions at Mayo in addition to his new role at Exact, company spokesman J.P. Fielder said. […]

Continue Reading

50 plans advance to semi-finals in 2018 Gov’s Biz Plan Contest

Fifty entries from 28 communities have advanced to the semi-final round of the 15th annual Wisconsin Governor’s Business Plan Contest, contest producers announced. The contestants were selected from a field of about 200 qualified first-round entries by an independent panel of 110 judges organized through the Wisconsin Technology Council and its programs, the Tech Council Innovation Network […]

Continue Reading

Exact Sciences: Cologuard® revenue increased 168 percent to $266 million

MADISON, Wis., Feb. 22, 2018 — Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $266 million and completed approximately 571,000 Cologuard tests during the year ended Dec. 31, 2017. Full-year 2017 revenue and Cologuard test volume grew 168 percent and 134 percent from 2016, respectively. Exact Sciences Corporation Logo (PRNewsfoto/EXACT […]

Continue Reading

Stratatech’s ExpressGraft begins human tests to treat diabetic foot ulcers

ExpressGraft-C9T1 is being used in first-round tests on a patient with diabetic foot ulcers — open sores that can affect patients with diabetes and can lead to amputation, said Mallinckrodt, the global pharmaceutical company whose Madison division, formerly Stratatech Corp., developed the tissue.   ExpressGraft-C9T1 is a genetically engineered, antimicrobial human skin substitute. It may […]

Continue Reading

Stem Cell Firm Cellular Dynamics to Provide Heart Cells to Takeda

Xconomy Wisconsin — Fujifilm said it plans to use stem cells developed by Cellular Dynamics International, a Wisconsin-based company it owns, as part of a new partnership between Fujifilm and Takeda Pharmaceutical that’s aimed at developing regenerative medicine therapies.   Takeda and Fujifilm, both headquartered in Japan, recently signed a contract giving Takeda the global […]

Continue Reading
Armune BioScience

Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences

The annual J.P. Morgan Healthcare Conference, held earlier this month in San Francisco, is a popular venue for biotech companies to announce new deals and milestones achieved. One such announcement from this year’s event has largely flown under the radar: Madison, WI-based molecular diagnostics company Exact Sciences acquired Armune BioScience, a cancer diagnostic startup with […]

Continue Reading
Women bioscience workers start group for networking, mentoring in Madison

Women bioscience workers start group for networking, mentoring in Madison

Getting more women into scientific jobs in the Madison area — that’s the goal of a new effort starting this month.   Women in Biohealth launches on January 17 with a roundtable discussion and networking event, organized by BioForward, the state’s biohealth advocacy organization. The idea is to “bring women together and to support young […]

Continue Reading
Cellular Dynamics International

Heart cells manufactured in Madison rocket into space

Stem cells made in Madison are flying high on the International Space Station. Cellular Dynamics International says its iCell cardiomyocytes are part of scientific tests being conducted in NASA’s new Bioculture System. They were launched into space aboard SpaceX’s commercial resupply mission on Dec. 15. “We are thrilled that CDI and its iPSC technology are […]

Continue Reading

Exact Sciences unveils more building plans at former Spectrum Brands site

Exact Sciences Corp. — the Madison company whose Cologuard DNA stool test screens for colorectal cancer — is building more than just a big laboratory building at its new campus just off Schroeder Road on the West Side. Exact is submitting plans to the city to construct a 77,000-square-foot addition onto the existing four-story office […]

Continue Reading

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARO – HBV

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) – WITH Research and Development facilities at University Research Park, today announced that it filed a regulatory submission to begin a Phase 1/2 study of ARO-HBV, which is being developed as a potentially curative therapy for patients with chronic hepatitis B virus (HBV) infection. Pending approval, Arrowhead intends to proceed […]

Continue Reading